Soraya MEBARKI's Avatar

Soraya MEBARKI

@sorayamebarki.bsky.social

PH en oncogeriatrie a l’HEGP, AP-HP

11 Followers  |  21 Following  |  1 Posts  |  Joined: 23.01.2025  |  1.4092

Latest posts by sorayamebarki.bsky.social on Bluesky

Preview
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial Nivolumab plus ipilimumab showed superior progression-free survival versus nivolumab across all treatment lines, with a manageable safety profile, in patients with microsatellite instability-high or m...

Nivo-Ipi dans le CCR métastatique MSI is le nouveau standard ! #CCR #OncoGI

www.thelancet.com/journals/lan...

11.02.2025 20:48 — 👍 0    🔁 0    💬 0    📌 0

@sorayamebarki is following 20 prominent accounts